Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
29.83
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
US Stocks Hold Steady Ahead Of Microsoft, Alphabet Earnings: Analyst Warns Of 'Big Air Pocket' In Pivotal Trading Week
January 30, 2024
After a record run, U.S. stocks could pause for a breather ahead of the tech earnings deluge that is expected to hit the Street this week.
Via
Benzinga
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
January 30, 2024
From
Pfizer Inc.
Via
Business Wire
Tuesday Talk: A Good Month - Two Days To Go
January 30, 2024
With two trading days to go in January the major stock indices seem to be set to end the month at new highs and there are fewer analysts trying to insist that the
Via
Talk Markets
Why NYSE:PFE is a Top Pick for Dividend Investors.
January 30, 2024
Balancing Dividends and Fundamentals: The Case of PFIZER INC (NYSE:PFE).
Via
Chartmill
Where Will Pfizer Be in 10 Years?
January 28, 2024
Pfizer stock has dropped about 50% from its peak.
Via
The Motley Fool
Earnings Scheduled For January 30, 2024
January 30, 2024
Companies Reporting Before The Bell • CommVault Systems (NASDAQ:CVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million.
Via
Benzinga
Investor Optimism Improves Slightly Ahead Of Big Earnings, Fed's Policy Decision
January 30, 2024
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the "Extreme Greed" zone on Monday.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Markets Stroll Higher Ahead Of Key Data; SMCI, FFIV, WHR Beat
January 29, 2024
One sign that we’re in a resilient bull market presently is that we’ve strolled into a potentially thorny period of economic and earnings data with market levels up more than a week straight, and we...
Via
Talk Markets
7 High-Yield Dividend Stocks With High-Upside Potential
January 29, 2024
With these enticing high-yield dividend stocks with potential for capital gains, investors can have their cake and eat it too.
Via
InvestorPlace
ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 29, 2024
WHY: NEW YORK, NY - (NewMediaWire) - January 29, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Pfizer's COVID-19 Treatment Paxlovid Will No Longer Be Available For Emergency Use After This Date, FDA Revises Label
January 29, 2024
FDA revises emergency use authorization for Pfizer's Paxlovid, impacting distribution and treatment of mild-to-moderate COVID-19. Transitions from March 8.
Via
Benzinga
Exposures
COVID-19
Product Safety
Pfizer Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
January 29, 2024
Pfizer Inc. (NYSE: PFE) is expected to release earnings results for its fourth quarter, before the opening bell on Jan. 30, 2024.
Via
Benzinga
A Bull Market Is Here: 2 Cheap Stocks to Buy Right Now
January 29, 2024
The past few years have been a roller-coaster ride for these stocks.
Via
The Motley Fool
Pfizer’s earnings growth trade at a deep discount, suddenly a buy
January 29, 2024
The healthcare sector is set to attract a new inflow of investment dollars, as seen in business activity and employment. Pfizer is the clear sector favorite
Via
MarketBeat
Topics
Economy
Exposures
Economy
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 28, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 28, 2024
WHY: NEW YORK, NY - (NewMediaWire) - January 28, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
January 28, 2024
The stock is high risk, but rewards could be great if all works out well for Novavax.
Via
The Motley Fool
5 Magnificent Stocks to Buy That Are Dirt Cheap
January 28, 2024
Attractive valuations plus solid underlying businesses qualify these stocks as magnificent picks right now.
Via
The Motley Fool
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 27, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 27, 2024
WHY: NEW YORK, NY - (NewMediaWire) - January 27, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
2 Ultra-High-Yield Dividend Stocks Down 47% or More to Buy Hand Over Fist Right Now
January 27, 2024
These stocks could be poised to rebound in a big way.
Via
The Motley Fool
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 26, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 26, 2024
WHY: NEW YORK, NY - (NewMediaWire) - January 26, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
3 Dividend Stocks to Buy and Hold for Long-Term Income in 2024
January 26, 2024
The critical nature of services provided by these dividend stocks for long-term income support generation of predictable cashflows.
Via
InvestorPlace
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
January 26, 2024
Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.
Via
InvestorPlace
European Medicines Agency Validates Type II Variation Application for PADCEV® (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
January 26, 2024
From
Pfizer Inc.
Via
Business Wire
How To Earn $500 A Month From Pfizer Stock Ahead Of Q4 Earnings Print
January 26, 2024
Pfizer Inc. (NYSE: PFE) is expected to release earnings results for its fourth quarter, before the opening bell on Jan. 30, 2024.
Via
Benzinga
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
January 25, 2024
WHY: NEW YORK, NY - (NewMediaWire) - January 25, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.